Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine

A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine. The temporal relationship between the COVID‐19 vaccination and orbital symptoms suggests a probable link between SARS‐CoV‐2 mRNA vaccine and...

Descripción completa

Detalles Bibliográficos
Autores principales: Grunenwald, Solange, Lethellier, Gabriel, Imbert, Philippe, Dekeister, Céline, Caron, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172587/
https://www.ncbi.nlm.nih.gov/pubmed/35685829
http://dx.doi.org/10.1002/ccr3.5926
_version_ 1784721903498297344
author Grunenwald, Solange
Lethellier, Gabriel
Imbert, Philippe
Dekeister, Céline
Caron, Philippe
author_facet Grunenwald, Solange
Lethellier, Gabriel
Imbert, Philippe
Dekeister, Céline
Caron, Philippe
author_sort Grunenwald, Solange
collection PubMed
description A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine. The temporal relationship between the COVID‐19 vaccination and orbital symptoms suggests a probable link between SARS‐CoV‐2 mRNA vaccine and this orbital inflammatory disease.
format Online
Article
Text
id pubmed-9172587
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91725872022-06-08 Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine Grunenwald, Solange Lethellier, Gabriel Imbert, Philippe Dekeister, Céline Caron, Philippe Clin Case Rep Case Reports A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine. The temporal relationship between the COVID‐19 vaccination and orbital symptoms suggests a probable link between SARS‐CoV‐2 mRNA vaccine and this orbital inflammatory disease. John Wiley and Sons Inc. 2022-06-07 /pmc/articles/PMC9172587/ /pubmed/35685829 http://dx.doi.org/10.1002/ccr3.5926 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Grunenwald, Solange
Lethellier, Gabriel
Imbert, Philippe
Dekeister, Céline
Caron, Philippe
Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
title Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
title_full Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
title_fullStr Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
title_full_unstemmed Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
title_short Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
title_sort orbital inflammatory disease following mrna sars‐cov‐2 vaccine
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172587/
https://www.ncbi.nlm.nih.gov/pubmed/35685829
http://dx.doi.org/10.1002/ccr3.5926
work_keys_str_mv AT grunenwaldsolange orbitalinflammatorydiseasefollowingmrnasarscov2vaccine
AT lethelliergabriel orbitalinflammatorydiseasefollowingmrnasarscov2vaccine
AT imbertphilippe orbitalinflammatorydiseasefollowingmrnasarscov2vaccine
AT dekeisterceline orbitalinflammatorydiseasefollowingmrnasarscov2vaccine
AT caronphilippe orbitalinflammatorydiseasefollowingmrnasarscov2vaccine

Ejemplares similares